Related Experiment Video
Updated: Mar 30, 2026
03:53
An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
Published on: October 10, 2025
627
Neurofibromatosis: Challenge for Anaesthetist
1Department of Anaesthesia and Critical Care, SNMC, Jodhpur, India.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|November 3, 2015
Summary
Neurofibromatosis type 1 (NF-1) is a genetic disorder affecting multiple body systems. Anesthetic management for NF-1 patients with gastrointestinal issues, like gastric outlet obstruction, requires careful consideration of associated complications.
Area of Science:
- Genetics
- Medical Science
Background:
- Neurofibromatosis type 1 (NF-1), also known as von Recklinghausen disease, is an autosomal dominant neurocutaneous syndrome affecting approximately 1 in 3000 births.
- NF-1 is characterized by the development of neurofibromas in the skin and other body systems, necessitating careful anesthetic management due to potential complications.
Observation:
- Patients with NF-1 have an increased risk (2-25%) of developing gastrointestinal (GI) neoplasms, with neurofibromas being the most common benign neoplasm (52%).
- Symptomatic GI involvement in NF-1 patients can lead to significant morbidity, highlighting the importance of thorough evaluation.
Findings:
- This report details the anesthetic management of a specific case involving a patient with NF-1 presenting with gastric outlet obstruction.
- The case underscores the need for anesthesiologists to be aware of and prepared for diverse NF-1-associated complications during surgical procedures.
Implications:
- Anesthetic strategies for NF-1 patients must comprehensively address potential abnormalities across musculoskeletal, respiratory, cardiovascular, central nervous, GI, and genitourinary systems.
- Proactive management and awareness of NF-1-related risks are crucial for preventing peri-operative complications and improving patient outcomes.
